Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US bill to boost trial participation in rare diseases awaits president's nod

This article was originally published in SRA

Executive Summary

The US House of Representatives has cleared legislation that allows patients with rare diseases to participate in clinical trials without losing their eligibility to claim public healthcare benefits1. The Improving Access to Clinical Trials Act, which was cleared by the Senate earlier this year2, has now been forwarded to President Barack Obama, who is expected to sign it into law.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS115596

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel